UBS Group AG - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 81 filers reported holding TCR2 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$351
-95.0%
234
-93.7%
0.00%
Q3 2022$7,000
-84.4%
3,699
-61.9%
0.00%
Q4 2021$45,000
-90.3%
9,701
-82.3%
0.00%
Q3 2021$466,000
+85.7%
54,728
+258.6%
0.00%
Q2 2021$251,000
-79.0%
15,262
-71.8%
0.00%
Q1 2021$1,194,000
+2495.7%
54,070
+3533.7%
0.00%
Q4 2020$46,000
+666.7%
1,488
+433.3%
0.00%
Q3 2020$6,000
-92.4%
279
-94.6%
0.00%
Q2 2020$79,000
+49.1%
5,169
-24.4%
0.00%
Q1 2020$53,000
-74.3%
6,835
-52.7%
0.00%
Q4 2019$206,000
+52.6%
14,453
+61.1%
0.00%
Q3 2019$135,000
+487.0%
8,972
+461.8%
0.00%
Q2 2019$23,000
+2200.0%
1,597
+4890.6%
0.00%
Q1 2019$1,000320.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$11,748,0004.96%
MPM BioImpact LLC 3,370,982$9,776,0002.72%
TANG CAPITAL MANAGEMENT LLC 3,641,606$10,561,0001.60%
Newtyn Management, LLC 692,799$2,009,0000.38%
K2 PRINCIPAL FUND, L.P. 1,078,070$3,126,0000.34%
HARBOR CAPITAL ADVISORS, INC. 64,341$187,0000.14%
Redmile Group, LLC 1,094,645$3,174,0000.12%
Artal Group S.A. 750,000$2,175,0000.12%
Oasis Management Co Ltd. 200,000$580,0000.10%
X-Square Capital, LLC 31,919$93,0000.06%
View complete list of TCR2 THERAPEUTICS INC shareholders